www.pharmacoreport .com is a news site providing information
about the top international pharmaceutical companies. This
website will also provide other information about these
pharmaceuticals like their address and locations, corporate
history, clinical trials, annual report, employees, careers and
jobs, health care products, research, sales, shares, dividend &
stock price, and patients’ assistance program.
Sanofi-Aventis has secured and maintained the position amongst the five biggest pharmaceuticals companies of the world that also include pharmaceutical giants like Pfizer, Bristol-Myer Squibb, Novartis and GlaxoSmithKline. The company is having it’s headquarter located in Paris, France and is engaged in consistent researching, developing, producing and commercializing of the different pharmaceutical products mainly in the prescription market segments. Moreover, the company also offers several products for sale under the OTC segments. Sanofi-Aventis including its subsidiary Sanofi-Pasteur has included 7 essential therapeutic sectors such as: cardiovascular, thrombosis, oncology, diabetes, central nervous system-CNS, internal medications and different vaccines.
The entity of Sanofi-Aventis was constituted sometimes during 2004 following Sanofi-Synthelabo duly amalgamated with Aventis when it made the aggressive takeover bid worth € 47.8 billion against Aventis. Sanofi-Synthelabo was formed in 1999 when Sanofi [which was the subsidiary of Total, earlier] amalgamated with Synthelabo [former subsidiary of L’Oreal] and this amalgamated company was located in Paris, France.
Aventis was shaped up during 1999 when Rhone-Poulenc S.A. amalgamated with Hoechst Marion Roussel which was constituted following the unification of Hoechst AG and Roussel Uclaf and Marion Merrell Dow. This new unified company was situated at Schiltigheim, near Strasbourg in France.
Sanofi-Aventis offers different medications for the treating the patients of several therapeutic sectors like: cardiovascular ailments, thrombosis related ailments, metabolic disorders, oncology diseases, central nervous system-CNS related disorders, several internal medications and different types of vaccines for preventing various diseases.
Some of the major and popular products of this company include: Lasix, Amaryl, Taxotere, Allegra, Rabipur, Frisium, Plavix, Cordarone, Stilnoct, Primacor IV, Valparin and Myoril.
ImmunoGen, Inc. Reports Second Quarter Fiscal Year 2007 Financial...
ImmunoGen, inc. (Nasdaq: IMGN), aimed a biopharmaceutical firm that develops, on anticancer therapeutic use its tumor activation Prodrug (ROOSTER).....More
Regeneron Reports Third Quarter Financial and Operating Results
,) Today announced financially and operation results for the third quarter of 2006th the firm has a net loss of $27.4 million, or $0.48 per share reported.....More
Sanofi-Aventis FY results in line; dividend to rise; CEO stays to...
PARIS (AFX) - Sanofi-Aventis said that entire year adjusted, brings was net profit 6,335 bln Eurs, on 26.1 pct and in line with analyst sand a predicting. .....More
Paris shares up midafternoon with help from Wall Street; Sanofi-Aventi...
Paris (AFX) - share prices were saw taken have chiefly more highly in the afternoon of trade, that was lifted of low gears, earlier, than an investor its cue of opening power.....More
Sanofi-Aventis unit to double output capacity for classic flu vaccines
PARIS (AFX) - its vaccine unit, Sanofi Pasteur has Sanofi-Aventis, will double said its capacity to produce vaccine for classic flu in the next few years. .....More
Sanofi-Aventis merger could hurt custom manufacturers.(Sanofi...
Sanofi-Synthelabo has how expects, shot down a 48-billion [Euro] ($60 billions) hostile offer to attain Aventis, (CW, Jan. 28, p. 7). .....More
Sanofi-Aventis, Bristol-Myers amend Plavix deal with Apotex; FTC...
PARIS (AFX) - Sanofi-Aventis and Bristol-Myers Squibb said, have that it something its come off with Canadaand Apotex over the blood of thinning. revised....More
USFDA says French drug maker Sanofi-Aventis& heart medicine...
Firm French pharmaceutical PARIS Sanofi-Aventis SOWED said Thursday, received that it a letter of that not permission by the USA food and drug administration for. hat...More
Judge considers Plavix patent validity
Through LARRY new master a lawyer for the Canadian manufacturer of a cheap generic version of the blood of thin Plavix Monday pressed a judge to clean the way for its sale, .....More
ImmunoGen, Inc. Announces that sanofi-aventis Has Entered into an...
,) Today announced registered has that sanofi-aventis into an option agreement, that enables it to win spread access to the Companyand, tumor activated.....More
Enquiry
Field Marked with asterisk (*) are mandatory
Name *
Email *
State/Country
Comments *
Most of the pharmaceuticals co manufacturing and r&d locations are in USA, UK, France, India, China, Australia, Canada, Ireland, Malaysia, Singapore and NJ – US. This website is for information only and not meant for any medical or health advice. Some of the information and the news might be outdated as of today.